01 1Torrent Pharmaceuticals Limited
01 1LAMOTRIGINE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-01-11
Pay. Date : 2022-01-07
DMF Number : 20289
Submission : 2007-02-22
Status : Active
Type : II
20
Torrent Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Torrent Pharma - Not Just Healthcare But Lifecare
One of their notable products is LAMOTRIGINE USP, with a corresponding US DMF Number 20289.
Remarkably, this DMF maintains an Active status since its submission on February 22, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 11, 2022, and payment made on January 07, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
